Green Plains Inc. (GPRE) Drops 13.59% on February 11

Equities Staff |

Green Plains Inc. (GPRE) was one of the Russell 2000's biggest losers for Thursday February 11 as the stock slid 13.59% to $12.97, a loss of $-2.04 per share. Starting at an opening price of $14.42 a share, the stock traded between $12.39 and $14.82 over the course of the trading day. Volume was 1.05 million shares over 9,981 trades, against an average daily volume of 735,256 shares and a total float of 37.89 million.

The losses send Green Plains Inc. down to a market cap of $491.43 million. In the last year, Green Plains Inc. has traded between $34.05 and $14.93, and its 50-day SMA is currently $19.77 and 200-day SMA is $23.05.

The stock has a P/E Ratio of 11.3.

Green Plains Inc is a producer, marketer and distributor of ethanol. The Company has four separate operating segments: Ethanol Production; Corn Oil Production; Agribusiness and Marketing and Distribution.

Green Plains Inc. is based out of Omaha, NE and has some 840 employees. Its CEO is Todd A. Becker.

For a complete fundamental analysis analysis of Green Plains Inc., check out’s Stock Valuation Analysis report for GPRE. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

PixarBio Corp

PixarBio Corp is a specialty pharmaceutical/biotechnology company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain.

Private Markets


Spotify is a online music service offering providing digital content from a range of record labels and artists. Users can browse through the interface by artist, album, genre, playlist, record…

Dropbox, Inc.

Dropbox is a service that allows their users to bring all photos, docs, and videos anywhere, and share them easily. Any file saved to Dropbox will automatically save to all…